During the past decade, Centro para el Desarrollo de la Medicina y de Asistencia Medica Especializada SC conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro para el Desarrollo de la Medicina y de Asistencia Medica Especializada SC" are "Atherosclerotic Cardiovascular Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Centro para el Desarrollo de la Medicina y de Asistencia Medica Especializada SC" in a lesser frequency.

Most popular intervention types in "Centro para el Desarrollo de la Medicina y de Asistencia Medica Especializada SC" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Efavaleukin alfa" (1 trials), "Evolocumab" (1 trials) and "Lp(a) Screening" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro para el Desarrollo de la Medicina y de Asistencia Medica Especializada SC" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Centro para el Desarrollo de la Medicina y de Asistencia Medica Especializada SC". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centro para el Desarrollo de la Medicina y de Asistencia Medica Especializada SC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro para el Desarrollo de la Medicina y de Asistencia Medica Especializada SC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".